Skip to main content

Want a detailed portfolio tracker?

NanoViricides (NNVC) P/E (2011 - 2026)

NanoViricides (NNVC) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM NanoViricides (NNVC) P/E is -3.78. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of NanoViricides (NNVC)

YearP/EChange
2026-3.78+57.05%
2025-2.41+15.92%
2024-2.08+56.59%
2023-1.33-27.07%
2022-1.82-63.04%
2021-4.92+190.35%
2020-1.69+37.45%
2019-1.23-30.32%
2018-1.77-70.15%
2017-5.93+19.16%
2016-4.97-54.28%
2015-10.88-91.53%
2014-128.46+403.62%
2013-25.51+124.56%
2012-11.36-69.59%
2011-37.35N/A

Comparison NanoViricides (NNVC) P/E with competitors

NanoViricides (NNVC) P/E is -3.78.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.98%
FGENFibroGen Inc0.24-106.35%
CHRSCoherus Biosciences Inc0.85-122.44%
FBIOFortress Biotech Inc0.95-125.10%
ORMPOramed Pharmaceuticals Inc1.50-139.75%
AGENAgenus Inc3.01-179.59%
INVAInnoviva Inc3.15-183.41%
VXRTVaxart Inc3.55-193.87%
CRMDCorMedix Inc3.63-195.96%
CVACCureVac N.V.4.45-217.57%
GLPGGalapagos NV4.86-228.50%
SRPTSarepta Therapeutics Inc4.88-229.11%
ABEOAbeona Therapeutics Inc5.39-242.48%
ABUSArbutus Biopharma Corp5.60-247.98%
ZVRAZevra Therapeutics Inc5.89-255.69%
SPROSpero Therapeutics Inc6.23-264.71%
CGENCompugen Ltd6.31-266.98%
RIGLRigel Pharmaceuticals6.87-281.74%
SLXNSilexion Therapeutics Corp7.30-292.95%
OMEROmeros Corporation9.26-344.85%
AUPHAurinia Pharmaceuticals Inc9.58-353.48%
PLXProtalix BioTherapeutics Inc10.89-388.02%
ACADAcadia Pharmaceuticals Inc11.73-410.17%
TBPHTheravance Biopharma Inc12.26-424.28%
ADMAAdma Biologics Inc12.42-428.40%
HRMYHarmony Biosciences Holdings Inc13.82-465.48%
SABSSAB Biotherapeutics Inc14.14-473.84%
NAGENiagen Bioscience Inc14.82-491.87%
INCYIncyte Corp15.82-518.44%
REGNRegeneron Pharmaceuticals Inc15.86-519.34%
PBYIPuma Biotechnology Inc17.32-557.92%
CPRXCatalyst Pharmaceuticals Inc17.44-561.19%
EXELExelixis Inc17.54-563.80%
TGTXTG Therapeutics Inc18.97-601.57%
MDXGMimedx Group Inc20.55-643.52%
XOMAXOMA Royalty Corp22.87-704.95%
ARGXArgen X SE24.30-742.59%
CTMXCytomX Therapeutics Inc24.82-756.43%
XOMAOXOMA Royalty Corp25.34-770.28%
HALOHalozyme Therapeutics Inc25.62-777.65%
XOMAPXOMA Royalty Corp25.67-778.88%
VRTXVertex Pharmaceuticals Inc27.99-840.36%
RPRXRoyalty Pharma plc - Class A28.69-858.68%
SLNOSoleno Therapeutics Inc29.02-867.35%
ASNDAscendis Pharma A/S30.09-895.65%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1102.63%
APLSApellis Pharmaceuticals Inc39.02-1131.97%
BMRNBiomarin Pharmaceutical Inc42.21-1216.35%
KRYSKrystal Biotech Inc45.34-1299.17%
ONCBeiGene Ltd69.54-1939.09%
PHARPharming Group N.V.75.03-2084.15%
TECHBio-Techne Corp101.96-2796.42%
VCELVericel Corp109.92-3007.01%
ALNYAlnylam Pharmaceuticals Inc117.96-3219.74%
GMABGenmab140.29-3810.17%
TLXTelix Pharmaceuticals Ltd162.15-4388.34%
CORTCorcept Therapeutics Inc212.86-5729.30%